VISTAGEN THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
VISTAGEN THERAPEUTICS, INC. (VTGN) had Deferred Tax Assets, Operating Loss Carryforwards of $70.86 million as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-15
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $70.86M.
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards $51.32M.
- 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards $46.46M.
- 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards $43.60M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $43.60M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-03-31 | $70.86M 10-K · filed 2026-06-15 | |
| 2025-03-31 | $51.32M 10-K · filed 2026-06-15 | |
| 2024-03-31 | $46.46M 10-K · filed 2025-06-17 | |
| 2023-03-31 | $43.60M 10-K · filed 2024-06-11 | $43.60M 10-K · filed 2023-06-28 |
| 2022-03-31 | $41.92M 10-K · filed 2023-06-28 | |
| 2021-03-31 | $33.59M 10-K · filed 2022-06-23 | |
| 2020-03-31 | $30.61M 10-K · filed 2021-06-29 | |
| 2019-03-31 | $27.19M 10-K · filed 2020-06-29 | |
| 2018-03-31 | $21.40M 10-K · filed 2019-06-25 | |
| 2017-03-31 | $30.18M 10-K · filed 2018-06-26 | $30.18M 10-K · filed 2017-06-29 |
| 2016-03-31 | $26.61M 10-K · filed 2017-06-29 | $26.61K 10-K · filed 2016-06-24 |
| 2015-03-31 | $23.05K 10-K · filed 2016-06-24 | |
| 2014-03-31 | $19.73K 10-K · filed 2015-06-29 | |
| 2013-03-31 | $19.01K 10-K · filed 2014-06-25 | |
| 2012-03-31 | $161.91K 10-K · filed 2013-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |